Deutsch
 
Mein Benutzerkonto  

ANMELDEN & VORTEILE SICHERN

  • Preise & Rabatte einsehen
  • Geschenke sichern
  • Angebote anfragen & online annehmen
JETZT ANMELDEN Noch nicht registriert? Konto hier erstellen!
Vergleich
Ergebnisse

Ergebnisse filtern

Typ
Specific against
Host
Clone
Applications
  1. 1.55 and 0.38 nM for human(1)
  2. 8.5 nM (pH=9.5) for type II arginase.(3)
  3. >30-fold selectivity over IRAK-1.(3)
  4. >80-fold selectivity over CB1 receptors in radioligand binding assay.(3)
  5. A AMG510 analogue(3)
  6. A cell-permeable benzochromene that selectively impairs the viability and growth of IGF2-overexpressing hepatocellular carcinoma cells(3)
  7. A dual inhibitor of JAK2 and S6K1 pathways(3)
  8. A membrane-impermeable sodium channel blocker(3)
  9. a metabolite of Methionine(3)
  10. a natural flavonoid extracted from the tropical plant Coronopus didymus(3)
  11. A new-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) for the treatment of HIV-1 infections(3)
  12. A non-peptide small molecule agonist of the PTH1 receptor(3)
  13. A nontoxic heat shock protein (HSP) coinducer and potentiator of the heat shock response.(3)
  14. a novel deuterated subtype-selective GABA(A) modulator. CTP may be potentially useful for treatment of neuropathic pain(3)
  15. A novel FTY720 analog that acts as PP2A activator(3)
  16. A novel Glucocorticoid receptor modulator.(1)
  17. a novel mammalian target of rapamycin (mTOR) inhibitor(3)
  18. a Novel MIC60 Inhibitor(3)
  19. A novel potent(6)
  20. a peptide anticoagulant(3)
  21. A potent(19)
  22. A potent nuclear receptor TR3 (Nur77)-specific targeting compound that can induce melanoma autophagy through a mitochondrial signaling pathway.(2)
  23. a relevant Rac1 activator in glioma invasion(3)
  24. a RIPK1 kinase inhibitor(3)
  25. a selective 5-HT1A receptor biased agonist(3)
  26. A selective GPR68 positive allosteric modulator (pEC50=6.83) with minimal PAM activity at the related proton-sensing GPCRs GPR4 and GPR65.(3)
  27. A selective TRPM8 channel blocker with pEC50 of 6.91 in Ca(2+) influx assay(1)
  28. A small molecule inhibitor of clathrin terminal domain and inhibits clathrin-mediated endocytosis.(3)
  29. A small molecule inhibitor of progesterone receptor membrane component 1 (PGRMC1) that alters the spectroscopic properties of the PGRMC1-heme complex.(1)
  30. A small-molecule probe that selectively kills cells induced to express mutant RAS.(3)
  31. acting by preventing fusion of the viral membrane with the host cellular membrane(3)
  32. activates both the cAMP and calcium signaling pathways..(3)
  33. acts as an amyloid-binding small molecule that promotes dendritic spine density and cognitive function in wild-type mice.(1)
  34. allosteric GPR55 antagonist(3)
  35. also known as C-21191(3)
  36. ameliorating muscular dystrophies and activating TFEB to correct lysosomal insufficiency in mdx mice(3)
  37. An orally active(3)
  38. and directly competing with cholesterol binding to the GRAMD1A StART domain(3)
  39. and modulates oxidative stress and purinergic signaling parameters.(3)
  40. and to reduce Rac1-GTP levels(3)
  41. Antagonist for G-protein Coupled Receptor 7 (GPR7)(3)
  42. Avanafil Impurity 8(1)
  43. binds to MFP-2(3)
  44. Bivalirudin(3)
  45. Blocking(253)
  46. blocks sodium current in voltage-clamped nociceptive DRG neurons.(3)
  47. brain penetrant PDE10A inhibitor with Ki of 4 nM.(3)
  48. BTA-EG4(1)
  49. but do not have the receptor subtype selectivity of CTP-354.(3)
  50. Cell Culture(76)
  51. CHIP(1)
  52. Chrysoeriol(3)
  53. Ciclopirox (CPX)(3)
  54. CLIA(1)
  55. competitive and orally active DPP4 inhibitor with potential for the treatment of type 2 diabetes.(3)
  56. CTP354(3)
  57. Cu-free click chemistry with readily synthesized biarylazacyclooctynones. The reaction of azides with strained alkynes(1)
  58. degrading HaloTag2 fusion proteins(3)
  59. direct thrombin inhibitor for anticoagulation in the setting of invasive cardiology(3)
  60. disrupts the SET/PP2A interaction devoid of immunosuppressive effects leads to the reactivation of PP2A.(3)
  61. Dot(21)
  62. Dual inhibitor for lysophospholipase 1 (LYPLA1) and lysophospholipase 2 (LYPLA2)(3)
  63. ELISA(1227)
  64. EM(48)
  65. exhibits potent antioxidant activity. Chrysoeriol shows significant inhibition of lipid peroxidation.(3)
  66. F13714 fumarate(3)
  67. FA(9)
  68. FC(49)
  69. First reported nonpeptidomimetic agonist on the G protein-coupled chemokine receptor CXCR-3(3)
  70. First-in-class Haspin inhibitor with a wide spectrum of anticancer effects(3)
  71. forming a covalent bond with the active site cysteines of PDI.(3)
  72. Fosciclopirox suppresses growth of urothelial cancer by targeting the γ-secretase complex. Fosciclopirox selectively delivers the active metabolite(3)
  73. Gallein (Pyrogallol phthalein) 是一种可抑制 G protein βγ (G beta-gamma complex(3)
  74. Ginkgolic acid C17:1 (GAC 17:1) 通过废除上游的 JAK2 和 Src 来抑制 STAT3 的组成性激活。Ginkgolic acid C17:1 可以诱导 PTEN 和 SHP-1 的大量表达。Ginkgolic acid C17:1 诱导肿瘤细胞凋亡。(3)
  75. GN44028 inhibits HIF-1α. GN44028 surpresses HIF-1α transcriptional activity without affecting both HIF-1α protein accumulation and HIF-1α/HIF-1β heterodimerization in nuclei under the hypoxic conditions(3)
  76. GW805758|DC Chemicals(1)
  77. Gβγ) 亚基与 PI3 kinase 相互作用的抑制剂。Gallein 抑制β-ionone的作用并表现出抗肿瘤活性。Gallein 可以用作生物染色剂。(3)
  78. Highly specific allosteric activator for the tumor-specific isoform of human pyruvate kinase M2 isoform (PKM2)(3)
  79. HPLC(1)
  80. Hydrophobic inducer of the degradation of stabilized proteins(3)
  81. IA(27)
  82. IB(10)
  83. IC(563)
  84. ICC(5)
  85. IF(32)
  86. IHC(7)
  87. including benzodiazepines(3)
  88. Induces Apoptosis via Mitochondrial Stress in β-Catenin Mutant Tumor Cells(3)
  89. induces M1/classical macrophage polarization(3)
  90. inducing a homeotic transformation in Hydra(3)
  91. inducing human myeloid tumor-selective apoptosis(3)
  92. inducing lysosomal Ca2+ release(3)
  93. inhibiting lipolysis in 3T3-L1 adipocytes and in primary human adipocytes(3)
  94. interferring with the interaction of Rac1 with Dock180(3)
  95. IP(192)
  96. irreversible inhibitor of protein disulfide isomerase (PDI)(3)
  97. IS(1569)
  98. IV(604)
  99. JNK1(3)
  100. L-Methionine sulfoxide (H-Met(O)-OH)(3)
  101. labelling plaques and cerebral amyloid angiopathies (CAAs)(3)
  102. leading to reprogramming of hepatic lipoprotein metabolism from lipogenesis to scavenging(3)
  103. LF(29)
  104. MCULE-3408819416|DC Chemicals(1)
  105. MHY-1685(3)
  106. Miclxin(3)
  107. more stable resveratrol analog(3)
  108. mouse and rat CB2(1)
  109. MS(42)
  110. Necrostatin-34 (Nec-34)(3)
  111. Negative control for GSK'963 (AOB9775). Novel highly potent and selective RIP1 inhibitor(3)
  112. Novel(3)
  113. Novel autophagy inhibitor(3)
  114. Novel blood brain barrier (BBB) penetrable two-photon imaging probe(3)
  115. Novel DNMT1 Selective Antagonist(3)
  116. Novel FABP4/5 inhibitor(3)
  117. Novel inhibitor of AMA1-RON2 interaction; Inhibitor of c-Src tyrosine kinase activity(3)
  118. Novel inhibitor of SARS-CoV replication(3)
  119. Novel inhibitor of TRPM6(3)
  120. Novel inhibitor of lactate dehydrogenase(3)
  121. Novel inverse agonist of estrogen-related receptor γ (ERRγ)(3)
  122. Novel Kv2.1 and Kv2.2 inhibitor(3)
  123. Novel modulator of Hydra head regeneration(3)
  124. Novel mucolipin 1 (ML1) agonist(3)
  125. Novel potent agonist of HTL/KAI2(3)
  126. Novel potent and cell-active PARG inhibitor(3)
  127. Novel potent and selective antagonist of human Complement C3a receptor(3)
  128. Novel potent and selective human Nav1.7 blocker(1)
  129. Novel potent and selective NADPH oxidase inhibitor(3)
  130. Novel potent and selective RIP3 kinase inhibitor(3)
  131. Novel potent FKBP12 ligand(3)
  132. Novel potent SIRT6 activator against whole histone substrate(1)
  133. Novel proteasome inhibitor(3)
  134. Novel Selective Histone Deacetylase 6 (HDAC6) Inhibitor with the Ability to Potentiate Immunotherapy in Melanoma Models(3)
  135. Novel selective PAD4 inhibitor(3)
  136. Novel selective uncompetitive inhibitor of DNA ligase I (LigI)(3)
  137. Novel SIRT6 activator(3)
  138. Novel specific Rac1 inhibitor(3)
  139. Novel suppressor of plant immune responses(3)
  140. Novel upregulator of TRIB1 expression(3)
  141. Novel VISTA (V-domain immunoglobulin suppressor of T-cell activation) agonist(6)
  142. NQTrp(3)
  143. NT(3)
  144. or p38 kinase activity.(3)
  145. orally active and S1P3-sparing S1P1 agonist(3)
  146. orally active cannabinoid CB2 receptor inverse agonist with Ki of 35.9(1)
  147. orally bioavailable IRAK-4 inhibitor that potently inhibits human and rat IRAK-4 activity with subnanomolar order(3)
  148. other(2650)
  149. particularly percutaneous coronary intervention.(3)
  150. PCR(6)
  151. PLA(23)
  152. potent(6)
  153. Potent and ATP-binding site inhibitor of GSK-3(3)
  154. Potent and selective blocker for TMEM16A/Anoctamin-1 (ANO1)(3)
  155. Potent and selective mGluR8-specific orthosteric agonist(3)
  156. Potent and selective non-peptide vasopressin V1A receptor antagonist; devoid of agonist activity. Displays high affinity and efficacy at both rat (KI=1.6 nM) and human (KI -1.1 - 6.3 nM) V1A receptors.(3)
  157. Potent and specific liver X receptor (LXR) dual agonist of LXRalpha and LXRbeta(3)
  158. Potent mGluR5 PAM modulator(3)
  159. promoting mesoderm and definitive endoderm differentiation of human embryonic stem cells through alteration of magnesium homeostasis(3)
  160. protecting cardiac against mitochondrial damage following H/R(3)
  161. provides opportunities to improve hCSC-based myocardial regeneration.(3)
  162. R isomer of SEP-363856.(3)
  163. readily forms a triazole product without the need for a toxic catalyst.(1)
  164. reduce the transmission of certain nerve signals. Several classes of widely used drugs target GABAA receptors(3)
  165. respectively.(1)
  166. RNAi(3)
  167. Rottlerin (Mallotoxin.(3)
  168. SDS-PAGE(1608)
  169. selective(10)
  170. selective cannabinoid receptor CB2 agonist with Ki of 7.1 nM(3)
  171. selective GLP-1 agonist with EC50 of 101 nM.(3)
  172. selective human Arginase inhibitor with Ki of 0.25 uM (pH=7.5)(3)
  173. Selective RIP3 kinase inhibitor(3)
  174. selectively killing BRCA-mutant and PARP inhibitor-resistant cancer cells(3)
  175. selectively kills cancer cells while exhibiting minimal toxicity toward normal cells.(3)
  176. selectively targeting cholesterol transfer protein GRAM domain-containing protein 1A (GRAMD1A)(3)
  177. shows antidepressant-like properties after a single administration in the mouse model of chronic mild stress.(3)
  178. significantly inhibiting the proliferation and migration of pancreatic ductal adenocarcinoma (PDAC) cells in vitro and markedly suppressing the tumor growth in a PDAC tumor xenograft model(3)
  179. spasticity and anxiety disorders. GABAA receptors are found in the nervous system and(3)
  180. specific TOPK inhibitor that has no effect on ERK1(3)
  181. stabilizes RIPK1 kinase in an inactive conformation by occupying a distinct binding pocket in the kinase domain.(3)
  182. stimulates the expression of IGFBP-1 and SOCS-3 through activation of STAT6.(3)
  183. stimulating activity for Arabidopsis seed germination(3)
  184. subtype-selective α3β4 nAChR partial agonist with Ki of 0.62 nM.(3)
  185. such as cyclooctynes(1)
  186. suggesting that GN44028 probably affectes the transcriptional pathway induced by the HIF-1α/HIF-1β heterodimer.(3)
  187. targeting Nox4 in TGFβ-induced lens epithelial to mesenchymal transition(3)
  188. The first-in-class dual inhibitor of ENL (Kd = 754 ± 45 nM) and its paralog AF9 (Kd = 523 ± 53 nM)(3)
  189. the prodrug of the active compound VM-1500A..(3)
  190. thereby suppressing injury(3)
  191. to the entire urinary tract. Ciclopirox has anticancer activity in a number of solid and hematologic malignancies.(3)
  192. WB(1394)
  193. when activated(3)
  194. with no activity for TRPV4 (pEC50<4.6).(1)
Isotype
Hersteller

Molecules

1259551 Artikel

pro Seite

Seite:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
Name PDF Typ Clone Specific against Appl. Host ArtNr. Menge ✓ Preis
FK-­506 (Tacrolimus) Chemicals Other DCC-DC1001-100mg

DCChemicals 		100 mg Anmelden
Vergleichen
Carfilzomib (PR-­171) Inhibitors Other DCC-DC1002-100mg

DCChemicals 		100 mg Anmelden
Vergleichen
NSC632839 Inhibitors Other DCC-DC10001-100mg

DCChemicals 		100 mg Anmelden
Vergleichen
Salermide Inhibitors Other DCC-DC10002-100mg

DCChemicals 		100 mg Anmelden
Vergleichen
PF-­06291874（glucagon receptor antagonists-­4） Chemicals Other DCC-DC10003-100mg

DCChemicals 		100 mg Anmelden
Vergleichen
SHP099 free base Inhibitors Other DCC-DC10004-500mg

DCChemicals 		500 mg Anmelden
Vergleichen
CCT196969 Inhibitors Other DCC-DC10005-100mg

DCChemicals 		100 mg Anmelden
Vergleichen
RSV-­604 Inhibitors Other DCC-DC10006-100mg

DCChemicals 		100 mg Anmelden
Vergleichen
Ibiglustat(Genz-­682452） Inhibitors Other DCC-DC10007-100mg

DCChemicals 		100 mg Anmelden
Vergleichen
Avitinib maleate Inhibitors Other DCC-DC10008-100mg

DCChemicals 		100 mg Anmelden
Vergleichen
Avitinib free base Inhibitors Other DCC-DC10009-100mg

DCChemicals 		100 mg Anmelden
Vergleichen
Pirmenol hydrochloride Chemicals Other Blocking DCC-DC10012-100mg

DCChemicals 		100 mg Anmelden
Vergleichen
Mirogabalin Chemicals Other DCC-DC10013-100mg

DCChemicals 		100 mg Anmelden
Vergleichen
2-­PMPA(NAALADaseinhibitor) Inhibitors Other DCC-DC10014-100mg

DCChemicals 		100 mg Anmelden
Vergleichen
MELK-­8a Inhibitors Other DCC-DC10015-100mg

DCChemicals 		100 mg Anmelden
Vergleichen
Pleconarilis Inhibitors Other DCC-DC10016-100mg

DCChemicals 		100 mg Anmelden
Vergleichen
EED-­226 Inhibitors Other DCC-DC10017-100mg

DCChemicals 		100 mg Anmelden
Vergleichen
Atrasentan hydrochloride Chemicals Other DCC-DC10018-100mg

DCChemicals 		100 mg Anmelden
Vergleichen
Fluticasone furoate Chemicals Other DCC-DC10020-100mg

DCChemicals 		100 mg Anmelden
Vergleichen
Batefenterol Chemicals Other IS DCC-DC10021-100mg

DCChemicals 		100 mg Anmelden
Vergleichen
PF06840003 Inhibitors Other DCC-DC10022-100mg

DCChemicals 		100 mg Anmelden
Vergleichen
UNC-­1079 Inhibitors Other DCC-DC10024-100mg

DCChemicals 		100 mg Anmelden
Vergleichen
TPPU Inhibitors Other DCC-DC10025-100mg

DCChemicals 		100 mg Anmelden
Vergleichen
B02 Chemicals Other other DCC-DC10026-100mg

DCChemicals 		100 mg Anmelden
Vergleichen
Importazole Inhibitors Other DCC-DC10027-100mg

DCChemicals 		100 mg Anmelden
Vergleichen
Name Preis
FK-­506 (Tacrolimus) Anmelden FK-506 (Tacrolimus)
Typ Chemicals
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 mg
Lieferbar
Carfilzomib (PR-­171) Anmelden Carfilzomib (PR-171)
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 mg
Lieferbar
NSC632839 Anmelden NSC632839
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 mg
Lieferbar
Salermide Anmelden Salermide
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 mg
Lieferbar
PF-­06291874（glucagon receptor antagonists-­4） Anmelden PF-06291874（glucagon receptor antagonists-4）
Typ Chemicals
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 mg
Lieferbar
SHP099 free base Anmelden SHP099 free base
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 500 mg
Lieferbar
CCT196969 Anmelden CCT196969
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 mg
Lieferbar
RSV-­604 Anmelden RSV-604
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 mg
Lieferbar
Ibiglustat(Genz-­682452） Anmelden Ibiglustat(Genz-682452）
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 mg
Lieferbar
Avitinib maleate Anmelden Avitinib maleate
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 mg
Lieferbar
Avitinib free base Anmelden Avitinib free base
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 mg
Lieferbar
Pirmenol hydrochloride Anmelden Pirmenol hydrochloride
Typ Chemicals
Clone
Specific against Other
Appl. Blocking
Host
ArtNr.
Menge 100 mg
Lieferbar
Mirogabalin Anmelden Mirogabalin
Typ Chemicals
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 mg
Lieferbar
2-­PMPA(NAALADaseinhibitor) Anmelden 2-PMPA(NAALADaseinhibitor)
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 mg
Lieferbar
MELK-­8a Anmelden MELK-8a
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 mg
Lieferbar
Pleconarilis Anmelden Pleconarilis
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 mg
Lieferbar
EED-­226 Anmelden EED-226
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 mg
Lieferbar
Atrasentan hydrochloride Anmelden Atrasentan hydrochloride
Typ Chemicals
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 mg
Lieferbar
Fluticasone furoate Anmelden Fluticasone furoate
Typ Chemicals
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 mg
Lieferbar
Batefenterol Anmelden Batefenterol
Typ Chemicals
Clone
Specific against Other
Appl. IS
Host
ArtNr.
Menge 100 mg
Lieferbar
PF06840003 Anmelden PF06840003
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 mg
Lieferbar
UNC-­1079 Anmelden UNC-1079
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 mg
Lieferbar
TPPU Anmelden TPPU
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 mg
Lieferbar
B02 Anmelden B02
Typ Chemicals
Clone
Specific against Other
Appl. other
Host
ArtNr.
Menge 100 mg
Lieferbar
Importazole Anmelden Importazole
Typ Inhibitors
Clone
Specific against Other
Appl.
Host
ArtNr.
Menge 100 mg
Lieferbar

1259551 Artikel

pro Seite

Seite:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
Kontakt

Hölzel Diagnostika Handels GmbH
Weinsbergstr 118a
D-50823 Köln

T +49 221 126 02 66
F +49 221 126 02 67

info@hoelzel.de

Über Hölzel
Service
Infothek
Spendenaktion Datenschutzsiegel

Copyright 2025 Hölzel Diagnostika Handels GmbH

To top